HRI Portal – health • research • innovation

  • About Us
    • About Research Canada
    • Sponsors
    • Contact
  • Information on Health Research
    and Innovation in Canada
    • The Current State of Health Research
      and Innovation in Canada
    • Research and Innovation in Action
    • Responding to and Recovering from the COVID-19 Pandemic
    • CanadaSpeaks! 2019
    • Patient Stories
    • What’s Being Said:
      Blog and News
  • Resources for
    Advocates
    • Advocacy Messages
    • Tips for Effective Advocacy
      • Quick Tips for Effective Advocacy
      • Meeting with Candidates: Policy Questions and Answers
      • Using Social Media for Health Research Advocacy
      • Maximizing Your Impact: Town Halls
    • About Your Candidates
    • Advocates’ Toolkit
  • Resources for
    Candidates
    • Information on Health Research and Innovation

What's Being Said

Voir en Français
  1. Home
  2. › Information on Health Research and Innovation in Canada
  3. › What's Being Said
  4. › Investing in Science for Canada’s Future Prosperity and Well-Being of Canadians
Investing in Science for Canada’s Future Prosperity and Well-Being of Canadians

Investing in Science for Canada’s Future Prosperity and Well-Being of Canadians

September 2, 2021August 26, 2021

During the past 18 months, Canadians have gained significant clarity on the need to address our health innovation challenges such as the funding and expertise gap to move scientific discoveries from the laboratory to preclinical development and clinical trials. As a result, Canada cannot take advantage of the many investments it has made in discovery science and remains a target for foreign takeovers. Many of our exciting technologies, and the scientists that discover them, leave for our neighbour to the south.

To compete in this global market and advance Canada’s innovation efficiency, it is critically important to invest in R&D funding shortfalls and organizations delivering measurable value. The 2021 Biomanufacturing and Life Sciences Strategy is an important step in this direction. It is aligned to the current BioCanRx modus operandi: accelerating the development of novel immunotherapies for the treatment of cancer for the benefit of patients.

By addressing structural issues that hamper bench to bedside translation, we will be better situated to advance made-in-Canada innovation, such as vaccines and immunotherapies. The national BioCanRx network bridges the gap between promising early-stage technologies and their clinical evaluation by taking a comprehensive, multi-disciplinary, ecosystem approach. Taking invention to innovation requires essential ingredients: preclinical research funding, training, GMP biomanufacturing and clinical trial funding. This all works together in minimum time to support the ultimate end user: the patient.

Our country is home to incredible, inventive minds. Laboratories in academic, government and private facilities are at the cutting-edge of great science. Strong partnerships and mission alignment between these sectors mean everyone is working to advance common priorities, share risk and accelerate impacts. BioCanRx urges all federal parties to commit to predictable, long-term investments in this comprehensive approach so Canada will be ready to apply it to any scientific challenge and improve future economic prosperity and the well-being of Canadians.

BioCanRx is Canada’s Immunotherapy Network. Our vision is to cure patients and enhance the quality of life of those living with cancer. We invest in leading edge immune oncology research translating world-class technologies from the lab into early phase clinical trials. BioCanRx is the only national not-for-profit network composed of academic health centres focused on connecting and aligning research investments, expertise, infrastructure, skills training, biomanufacturing and private sector partnerships to bring novel made-in-Canada immunotherapies to patients.

Research and Innovation: Solutions for the Undecided Voters’ PrioritiesNew normal, same cancer
  • AstraZeneca
  • Innovative Medicines Canada - Médicaments novateurs Canada
  • Roche

Contact Us

Tweets

  • 2 hours ago In today's Media Digest: First patient treated in world-first cell therapy trial to heal the lungs of preterm babie… https://t.co/ZIdvL90clj
  • 17 hours ago The incredible @MHRCanada has joined our Alliance! This organization is improving the lives of Canadians by advanc… https://t.co/ucqsr79NdT
  • 18 hours ago Thank you to our Innovator Sponsors, @Carleton_U, @UWaterloo and @UHN, for supporting our upcoming… https://t.co/uQZbqxB4gr
  • 21 hours ago RT @hri_portal: In today's Media Digest: Prolonged and repeated use of antibiotics has negative effect on gut microbiome and gut resistome…

About Research Canada

Research Canada is a national, broad-based alliance dedicated to increasing investments in health research through collaborative advocacy. We believe health research is shared benefit, shared responsibility and an investment in Canada’s future. We engage government, academia, industry and non-profit sectors to build support for balanced and long-term health research funding – investments that strengthen Canada’s innovation system and lead to better health, sustainable health care, new commercialization opportunities, and skilled jobs for Canadians.

Research Canada: An Alliance for Health Discovery / Recherche Canada : Une alliance pour les découvertes en santé
Your Candidates, Your Health Your Candidates, Your Health
HRI Portal – health • research • innovation
  • Sponsors
  • Health Research
    and Innovation
  • Resources for
    Candidates
  • Resources for
    Advocates
  • What’s Being Said:
    Blog and News
  • Contact
Research Canada/Recherche Canada © 2019 | All Rights Reserved | Tous droits réservés.